Begin with the proposal and fascia lens, follow a connected system, or jump to the practical possibilities. The chapters are grouped by purpose; earlier chapter links still lead to the same subjects.
Observation → proposed connection → open question. Keep those steps separate as you read. The synthesis includes established findings, interpretation, and frontier ideas. Its evidence vocabulary expresses the author’s assessment.
Read at your own depth
Start with a diagram, look up a term, or follow a question. The full report remains below.
Plain-language glossary · 12 terms
Fascia
Connective tissue that surrounds, separates, and connects structures in the body. Read in context →
Extracellular matrix (ECM)
The material outside cells that provides structure and a surrounding environment for them. Read in context →
Hyaluronic acid / hyaluronan (HA)
Two names for the molecule discussed in section 6 in relation to fascial sliding layers. This passage concerns tissue biology, not an oral supplement protocol. Read in context →
Fasciacytes
Specialized cells described in the report as producing hyaluronan in fascia. Read in context →
Nociception
The nervous system’s processing of potentially harmful stimuli. It is related to, but not identical with, the experience of pain. Read in context →
Sensitization
Increased responsiveness within pain-related processing. The report explores both incoming peripheral signals and central processing. Read in context →
Autonomic
Related to largely automatic regulation, such as heart rate and blood-vessel responses. Read in context →
Orthostatic
Related to being upright; here, symptoms such as dizziness or a racing heart on standing. Read in context →
Post-exertional malaise (PEM)
Delayed worsening of symptoms after exertion, beyond ordinary short-lived tiredness. The report treats this as a reason to reconsider progression. Read in context →
Phenotype
An observable pattern of features. In this report it is a research route, not a self-diagnosis. Read in context →
Mechanotransduction
How cells respond to mechanical forces by changing biological activity. Read in context →
N-of-1
A structured investigation of one person’s response to a change; it cannot establish a general treatment effect. Read in context →
Questions readers may ask
Where should I start?
Choose one concern in the exploration map, or start with the systems diagram. You do not need to read the whole report before following a question.
Ask what was actually measured, in whom, and whether the proposed connection was tested. The report’s labels separate observations from inferences and frontier ideas.
Keep that observation. The report asks readers to measure specific outcomes, consider other explanations, and modify or abandon an experiment when the results do not support it.
No. Evidence about a mechanism, ingredient, or separate intervention does not validate a branded formulation. The educational site and product business share an owner.
Reading aids summarize this report and the author’s stated hypothesis. Follow the section links for its evidence and references.
A systems-biology research report on maintaining loops, phenotypes, leverage points, frontier hypotheses, and self-experimentation
Reader edition 1.1 · October 16, 2026
This is a working synthesis of the Functional Fascia idea: persistent symptoms may be partly maintained by interactions between tissue, sensation, recovery, and daily life. Fascia is the organizing lens. The report brings the observations that prompted this idea together with the connections and practical questions proposed here.
This is a research and public-discussion reference, not diagnosis or
individualized medical care. It deliberately integrates controlled
trials with mechanistic physiology, adjacent-field research,
observational findings, clinician/therapist experience, case reports,
community discussion, and convergent inference.
Evidence language
OBSERVED: direct human measurement or established physiology.
SUPPORTED: several independent lines support the relationship.
CONVERGENT: different evidence streams point in the same
direction without testing the complete hypothesis.
INFERRED: biologically coherent connecting arrow that remains
unproven.
FRONTIER: early, practice-derived, adjacent-field, or
community-generated hypothesis worth measuring rather than assuming.
The proposal & the fascia lens
Executive synthesis
This report explores fibromyalgia as a heterogeneous adaptive
systems state: several interacting processes may help maintain a pattern. Peripheral nerves,
immune signaling, fascia and extracellular matrix, energy metabolism,
microcirculation, autonomic function, sleep/circadian biology, gut
metabolites, connective-tissue stability, emotional processing, and
predictive/interoceptive processing can all participate. None needs to
be universal.
The practical question is not only what initiated illness? but
what is maintaining the state now? If feedback loops help stabilize one
another, the initiating trigger may no longer be the only useful
point of investigation. That is the proposal this report develops.
A subsystem can improve without immediate pain relief. In a randomized
fibromyalgia trial, creatine raised intramuscular phosphocreatine by
about 80% and improved strength while pain, sleep, cognition, and
quality of life did not materially change. That is systems information:
the energy/capacity outcome changed without a corresponding broad
symptom change. Other maintaining loops are one proposed explanation; the
trial did not measure those loops or establish which mechanism limited
symptom improvement.
Psychological and physical explanations are not opposites.
Fibromyalgia-specific Emotional Awareness and Expression Therapy (EAET)
research found benefits on some pain and functional outcomes, while its
primary pain outcome at six months did not outperform education. Small-fiber pathology and passive-transfer IgG studies show
that peripheral biology can also generate nociceptive input. Both can be
true in the same person.
Movement may be the broadest home-accessible adaptive signal. Repeated
muscle contraction affects energetic demand, AMPK/PGC-1α signaling,
vascular shear and nitric oxide, insulin sensitivity, lymph propulsion,
extracellular-matrix mechanotransduction, neurotrophic signaling,
proprioception, and threat prediction.
Surrounding every system: daily demands, environment, and recovery.
Hover or focus a system for a short explanation. Select it for context and a follow-up question.
Follow a connection
Each system has its own evidence and its own unanswered questions.
Nerves & pain: connection & context
The proposed connection
Fascial or other peripheral input is one proposed contributor to ongoing sensitization. Small-fiber abnormalities occur in a subgroup; they do not identify fascia as the cause.
How to read the evidence
A nerve finding and a fascia hypothesis answer different questions. The report considers multiple possible sources of pain input.
Does burning or electric pain prove a fascia problem?
No. The report routes these symptoms toward evaluation of nerve-related and other causes, rather than treating the sensation as a diagnosis.
The report places immune signaling, peripheral nerves, and tissue responses in an interacting network. The direct link back to fascia remains a question within the author’s model.
How to read the evidence
Animal-transfer findings and early human studies are not interchangeable with evidence for a specific treatment.
Does this mean everyone should try a microbiome treatment?
No. The report distinguishes investigating genuine gut pathology from assuming that a probiotic or other microbiome intervention will help.
The proposed connection is through loading, local demand, circulation, and tissue adaptation. The report considers whether these are mismatched in some people.
How to read the evidence
The creatine example improved muscle energy storage and strength without materially improving pain. The report uses this to distinguish a subsystem result from a whole-person result.
What should I measure besides pain?
Choose an outcome relevant to the question: daily function, strength, fatigue, or recovery. A change in one does not establish that every part of the model changed.
The report connects disrupted sleep and autonomic state with pain sensitivity and guarding. Fascia is part of the wider proposed loop, rather than a measured explanation for every sleep problem.
How to read the evidence
Sleep and autonomic findings have their own evidence. Their place in a fascia-centered causal chain is an interpretation.
Where does unrefreshing sleep lead in the report?
To sleep timing and sleep-disorder evaluation, including the possibility of apnea or restless legs when appropriate.
Muscle contraction and tissue loading are connected to extracellular-matrix remodeling, circulation, energy demand, and sensory learning in the report.
How to read the evidence
A general role for movement does not establish that one exercise program or sequence fits every person.
What if activity makes me worse later?
The report gives delayed, prolonged worsening priority over automatic progression. Follow the recovery branch and discuss pacing and assessment.
The report proposes that guarding can sometimes compensate for instability. Sensory interpretation and movement confidence may also influence the pattern.
How to read the evidence
Feeling tight does not show which mechanism is active. The report separates increasing range from increasing control.
Should all tight areas be stretched or released?
The report says no: instability changes the question toward control, proprioception, and appropriate strength work.
Fascia & extracellular matrix: connection & context
The proposed connection
The report connects tissue gliding, mechanical loading, peripheral input, and adaptation. This map puts those questions at the center of a wider systems model.
How to read the evidence
Anatomy and HA-rich sliding layers are distinct from the hypothesis that fascia maintains fibromyalgia. A treatment response alone cannot prove the proposed mechanism.
Does the center of the diagram mean a single root cause?
No. It expresses the author’s research focus. The report allows different initiating triggers and maintaining loops in different people.
This view reflects the author’s fascia-centered interpretation of the report. Dashed lines mark proposed relationships, not established causes of fibromyalgia. Select a system to open its context and report links.
The map proposes relationships that can run in both directions. The
following is a conceptual account to examine, not a measured sequence in
every person. Persistent nociceptive input can
increase guarding. Guarding changes loading. Reduced loading changes
capacity, microcirculation and ECM remodeling. Pain disrupts sleep. Poor
sleep changes pain gain, immune signaling and autonomic state. Fear and
prediction amplify sensory input. Reduced activity worsens metabolic and
vascular capacity.
Fascia, hyaluronan (hyaluronic acid), and extracellular matrix
Carla Stecco's group identified hyaluronan-rich sliding layers in deep
fascia and specialized HA-producing cells called fasciacytes. HA
facilitates fascial gliding. Altered HA organization, aggregation, or
viscosity has been proposed as a contributor to densification and
myofascial pain.
Ginevra Liptan proposed that persistent fascial/peripheral input could
help maintain central sensitization in fibromyalgia. Randomized
myofascial-release trials provide a clinical signal but do not prove
that HA biology is the mechanism.
Brooke McPoyle's Fascia Flow is best described as an applied frontier
synthesis: gentle sustained compression, feet/lower legs first,
gradual progression upward, and rejection of "pain equals release."
A stronger systems sequence is:
heat → release → active movement → load
Release changes the immediate sensory/mechanical environment. Active
movement explores the changed range. Loading provides a
mechanotransductive remodeling signal.
Figure 3
From anatomy to a treatment hypothesis
Observed anatomyHyaluronan-rich sliding layers and HA-producing fasciacytes.
Proposed mechanismAltered HA organization or viscosity may affect gliding and contribute to pain.
Clinical questionCould changing the local mechanical or sensory environment improve symptoms?
A benefit from myofascial release would not, by itself, prove that hyaluronan is the mechanism.
Read alongside section 6. The report distinguishes measured anatomy, a proposed pain mechanism, and clinical outcomes. These are different kinds of evidence.
Hypermobility and structural stability
Fibromyalgia overlaps substantially with hEDS/HSD populations. This does
not mean hypermobility explains all fibromyalgia.
The useful inference is that some chronic muscular tension may be the
nervous system solving an instability problem. Repeatedly stretching and
releasing tight tissue without increasing control can remove
compensation without solving the input.
Priority shifts toward proprioception, isometrics, mid-range control,
progressive strength, movement confidence, and targeted rather than
indiscriminate release.
Figure 2
How a pattern may keep itself going
Persistent pain inputThe report considers ongoing peripheral input as one possible starting point.
GuardingProtective tension can change how a person moves.
Changed loadingMovement, tissue loading, and activity patterns shift.
Changed capacityThe report links these shifts to capacity, circulation, and matrix remodeling.
↺ Possible feedback into pain and guarding
A proposed maintaining loop from section 1. Each arrow is a relationship to investigate; the sequence need not occur in every person. Sleep and other systems may also feed into it.
Self-classification: routing rather than diagnosis
Pattern
Clues
First research route
Myofascial/mechanical
stiffness after rest; restricted ROM; heat/pressure/movement responsive
heat → gentle MFR → active mobility → progressive loading
GI symptoms; food-reactive; postinfectious/autoimmune clues
investigate pathology; food diversity; metabolic health
Threat/emotional
stress-linked symptoms; fear of sensation/movement; suppression
EAET/PRT-style processing + somatic exposure
Overrides: PEM-like delayed crashes mean stress is only useful if
recovery absorbs it. In hypermobility, muscular tightness may be
functional stabilization.
Connected systems
Peripheral nerves and small-fiber pathology
Evidence position: SUPPORTED subgroup phenomenon.
A 2025 review summarizes substantial evidence for small-fiber pathology
in a subgroup of people diagnosed with fibromyalgia. Fibromyalgia and
small-fiber neuropathy are not interchangeable. Small-fiber
abnormalities may be causal contributors, downstream effects, comorbid
conditions, or biomarkers in different people.
This branch matters because it provides a concrete peripheral source of
nociceptive and autonomic input.
Implications: objective or strongly suggestive neuropathic symptoms
should increase interest in diabetes/insulin resistance, B12 and other
nutritional causes, autoimmune/Sjögren-like disease, postinfectious
causes, and medication/toxin context when clinically indicated.
Acetyl-L-carnitine is especially interesting because it has direct
fibromyalgia trials plus adjacent human peripheral-neuropathy
regeneration signals. PEA and ALA become more coherent in this
phenotype. Lion's mane remains a neurotrophic frontier hypothesis. TENS
may be valuable partly because it makes movement possible.
Immune signaling, autoantibodies, glia, and mast cells
Evidence position: CONVERGENT with strong mechanistic animal
evidence.
Goebel and colleagues purified IgG from people with fibromyalgia and
transferred it to mice. The mice developed mechanical/cold
hypersensitivity, reduced locomotor activity and grip strength, and loss
of skin innervation. Control IgG did not.
This does not establish that every case is autoimmune. It establishes
that peripheral immune factors from at least some patients can generate
a fibromyalgia-like sensory phenotype.
Immune signaling can affect peripheral nociceptors, dorsal-root-ganglion
neurons/glia, endothelium, small-fiber survival, fatigue, gut ecology
and mitochondrial/redox state.
The mast-cell branch is better treated as a phenotype when pain
clusters with flushing, hives, allergy/atopy, food reactions or
unexplained GI episodes than as a universal MCAS explanation.
In 2025, microbiota from fibromyalgia patients transferred into
germ-free mice produced pain plus immune/metabolic abnormalities.
Replacing fibromyalgia microbiota with healthy microbiota reduced pain
in mice. An open-label human FMT arm reported reduced pain and improved
quality of life.
Earlier work linked altered bile-acid-metabolizing bacteria and
circulating bile acids with pain/fatigue severity.
"Microbiome matters" does not mean "take probiotics." A negative
placebo-controlled probiotic trial is a reminder that the microbiome is
an ecosystem.
Practical low-risk levers: diverse whole foods, fiber as tolerated,
polyphenols, fermented foods when tolerated, metabolic health, avoiding
unnecessary antibiotics, and diagnosis of genuine GI pathology.
Mitochondria, ATP buffering, redox, and metabolic capacity
The energy branch is clearer when separated into ATP buffering, electron
transport/redox, mitochondrial biogenesis, mitophagy/quality control,
substrate handling, and training adaptation.
Creatine
In a 16-week randomized fibromyalgia trial, creatine increased muscle
phosphocreatine by about 80% and improved strength. Pain, sleep,
cognition and quality of life did not materially improve.
Rather than calling this a failed intervention, the systems
interpretation is that the ATP-buffering/capacity node moved while the
whole syndrome did not.
CoQ10
Small randomized fibromyalgia studies have reported symptom and
mitochondrial/inflammatory biomarker signals, commonly around 300
mg/day. Evidence is small but directly relevant.
ALC
ALC bridges mitochondrial metabolism and peripheral nerve biology and
has direct fibromyalgia trial evidence.
Second-wave energy experiments
Urolithin A: adjacent human evidence for mitophagy/mitochondrial
biomarkers and muscle endurance.
ALA: a redox and peripheral-neuropathy rationale. The direct
fibromyalgia crossover trial found no significant overall benefit
over placebo, so this is not positive fibromyalgia efficacy evidence.
Source: https://pubmed.ncbi.nlm.nih.gov/32773602/
NAC: glutathione/redox hypothesis.
B1/B2: foundational mitochondrial cofactors; correcting
insufficiency is more grounded than indiscriminate megadosing.
NR/NMN: NAD+/sirtuin biology is interesting;
fibromyalgia-specific evidence remains weak.
D-ribose: open-label fibromyalgia/CFS signal without strong
controlled replication.
AMPK, PGC-1α, mitochondrial biogenesis, and exercise
Repeated energetic stress from exercise activates AMPK and PGC-1α
signaling and drives mitochondrial remodeling. Exercise is therefore
information telling cells to build greater energetic capacity.
A 2026 meta-analysis of 14 resistance-exercise RCTs involving 871 women
found reductions in pain and disease impact, with progressive programs
performed roughly 2--3 times weekly showing clinically meaningful
benefit.
This is especially important in postinfectious/PEM-like phenotypes.
Microcirculation, nitric oxide, and oxygen delivery
Fibromyalgia muscle studies have reported microcirculatory, oxygenation,
lactate, and energetic abnormalities, but findings are inconsistent.
The stronger question is not "Are fibromyalgia muscles oxygen-starved?"
It is whether flow distribution, endothelial function, oxygen
extraction, and local metabolic demand are mismatched in a subgroup.
Home-accessible vascular inputs include repeated muscle contraction,
walking, aerobic conditioning, heat, metabolic health, and potentially
dietary nitrate/beetroot.
Niacin: nicotinic acid clearly increases peripheral cutaneous blood
flow. The next arrow---greater perfusion increases delivery/exposure of
neurotrophic compounds to distal nerves---is INFERRED, not
established. That makes it a mechanistic hypothesis rather than nonsense
or fact.
Autonomic regulation
Systematic-review evidence finds lower HRV, greater sympathetic
activity, and blunted autonomic responses to stressors in fibromyalgia.
Resistance training can improve HRV.
Practical branch:
slow comfortable breathing,
sleep restoration,
orthostatic measurements when symptomatic,
recumbent-to-upright conditioning,
hydration/electrolyte strategy when medically appropriate,
HRV biofeedback as a frontier self-regulation tool.
Sleep, circadian timing, and brain clearance
Sleep is both output and input. Pain fragments sleep; poor sleep
increases pain sensitivity and impairs recovery.
A 60-person fibromyalgia trial compared bright with dim morning light.
Both groups also stabilized sleep timing. Both improved significantly
and similarly, suggesting regular timing itself may have been an active
intervention.
Circadian foundation:
consistent wake time,
outdoor morning light,
bright/active daytime,
lower light in the evening,
regular sleep opportunity,
investigate apnea/RLS when indicated.
Blue-light glasses are most coherent late evening, not as an all-day
default.
Sleep, respiration, hemodynamics, circadian timing, and activity
plausibly influence glymphatic/meningeal-lymphatic physiology. Avoid
turning this into vague "detox" claims.
↺ The report treats these as interacting influences, rather than a fixed starting point. Select any part to read more.
Where does fascia enter this loop?
The author’s hypothesis asks whether persistent fascial or peripheral input contributes to pain and guarding. The loop also includes influences that need their own assessment, such as a sleep disorder.
Read the fascia hypothesis →Conceptual summary of sections 1, 11, 12, and 14. The diagram does not establish which influence is active in an individual.
Lymphatic movement
For peripheral lymph movement, the stronger physiological levers are
skeletal-muscle contraction, walking, calf pumps, diaphragmatic
respiration, and intrinsic lymphatic pumping.
Dry brushing can remain an optional skin/sensory ritual, but
evidence that it produces major systemic lymph clearance is weak.
Jump rope/rebounding can be relevant as calf-pump, coordination,
cardiovascular and loading stimuli when joint stability, pelvic-floor
status, autonomic tolerance and PEM status permit.
Interoception, predictive processing, emotion, and learned pain
The nervous system infers bodily state from incoming sensory information
plus context, expectation, memory, and learning. This does not make
symptoms imaginary.
In a 230-person fibromyalgia RCT, EAET did not outperform education on
the primary pain-severity outcome at six months. It showed benefits on
several secondary outcomes, including overall symptoms, widespread pain,
and physical functioning, with some advantages over CBT. The outcome and
comparison matter to the interpretation.
A secondary analysis found baseline pressure-pain tolerance predicted
differential EAET response. This is important: even the emotional/neural
branch may have identifiable responder phenotypes.
Adjacent chronic-back-pain Pain Reprocessing Therapy research shows that
changing beliefs about whether safe sensations signal tissue damage can
produce durable pain reversal in a subgroup, with benefits persisting at
five-year follow-up.
Vipassana / body scanning
Body scanning is coherent as:
interoceptive discrimination training,
repeated safe exposure to sensation,
practice reducing the automatic sensation→danger reaction,
detection of guarding before it escalates,
a before/after measurement tool.
A 2024 fibromyalgia mindfulness meta-analysis found
low-to-moderate-quality evidence for improvements in quality of life,
stress, insomnia and depression.
Endocannabinoid signaling
The endocannabinoid system regulates pain, stress, sleep, and immune
signaling.
Reviews report alterations in endocannabinoids and related lipids in
fibromyalgia. The older "clinical endocannabinoid deficiency" theory
remains a provocative but unproven unifying hypothesis.
The useful systems interpretation is that the ECS is another regulatory
network connecting pain, stress, immune tone, and sleep. This does not
establish that cannabis or cannabinoid products are universally
effective.
Sex, hormones, and life-stage biology
Fibromyalgia is strongly female-predominant. Sex hormones, immune
differences, connective tissue, sleep, and autonomic biology therefore
deserve study.
The evidence does not support a simplistic "low estrogen causes
fibromyalgia" story.
A better model is that reproductive transitions and hormonal state can
modulate multiple systems simultaneously and may alter phenotype or
treatment response.
Practices & emerging possibilities
Movement, mechanotransduction, and the "central" intervention
Movement is not one treatment.
Repeated contraction simultaneously affects:
ATP demand and mitochondrial signaling,
vascular shear and nitric oxide,
capillary demand,
insulin sensitivity,
lymph propulsion,
neurotrophic signaling,
extracellular-matrix mechanotransduction,
proprioception,
movement confidence,
sensory prediction.
This is why movement sits in the center of the model.
Heat, MFR, TENS, energy support, sleep restoration, and
emotional/predictive work may all be valuable partly because they make
this adaptive signal tolerable enough to repeat.
Tai chi
Tai chi is unusually interesting because it combines slow loading,
balance, breathing, attention, sensory retraining, and autonomic
regulation. Randomized fibromyalgia trials show meaningful benefit.
Figure 7
Let the response guide the next question
After activity, what pattern needs attention?
Recovery feels manageable
Consider the overall pattern across repeated activities, including daily function and recovery. A tolerable session alone is not proof that a progression is appropriate.
The report puts pacing and recovery ahead of automatic increases in exercise when delayed, prolonged crashes occur. This pattern warrants individual assessment.
The report separates instability from simple stiffness. Explore assessment, movement control, and stability rather than assuming more stretching is the answer.
These branches can overlap. They organize reading and a care conversation; they do not diagnose a condition or set an exercise dose.
Heat, hydrotherapy, and photobiomodulation
Balneotherapy/warm-water therapy has meta-analytic fibromyalgia evidence
for pain and Fibromyalgia Impact Questionnaire outcomes, although
protocols vary.
Heat may simultaneously affect comfort, tissue extensibility/viscosity,
blood flow, muscle tone, and willingness to move.
A coherent medium-day sequence is:
heat → fascia work → active mobility → progressive loading →
recovery
Photobiomodulation has an emerging fibromyalgia evidence base. A 2026
systematic review found multiple RCTs with generally favorable
short-term signals, though protocols are heterogeneous. It belongs in
the frontier/home-technology branch, not as a proven mitochondrial cure.
Metabolic health, insulin signaling, fasting, and autophagy
Fibromyalgia cohorts show associations with insulin-resistance indices.
Causality is not established, but metabolic health intersects
endothelium, peripheral nerves, mitochondria, inflammation, and
recovery.
Start with resistance training, walking, meal quality, and
daytime-aligned eating.
Human randomized data now provide an exploratory signal that
intermittent time-restricted eating can increase autophagic flux after
months. This is not fibromyalgia-specific.
Longer fasting is a stronger hormetic stressor. Judge it by energy,
sleep, orthostasis, training recovery, and nutritional adequacy rather
than assuming more fasting is better.
Fasting is better justified through nutrient sensing, insulin/ketone
metabolism, and autophagy than through claims of acutely raising BDNF.
Supplement and nootropic map
Candidate
Main node
Evidence position
Systems interpretation
Creatine monohydrate
ATP/phosphocreatine
supported direct fibromyalgia physiology
capacity/strength tool; subsystem benefit without direct pain benefit
Second-wave experiments: ALA, urolithin A, NAC, B-vitamin or NAD
hypotheses only after higher-signal variables are understood.
Avoid a kitchen-sink stack if the goal is learning.
Psilocybin-assisted therapy and the plasticity hypothesis
A 2025 University of Michigan open-label pilot enrolled five adults with
fibromyalgia. Participants received preparation and integration therapy
plus two psilocybin sessions. One month after the second session, pain
severity, pain interference, and sleep disturbance showed large
within-person improvements.
The sample is far too small and uncontrolled to estimate efficacy
reliably.
Important mechanistic observations:
psilocybin acts primarily through 5-HT2A signaling;
human imaging and preclinical work support altered network dynamics
and plasticity;
in the fibromyalgia pilot, pain and sleep improved while average
depression changed very little, weakening the simplest "they just
became less depressed" explanation;
psychedelic critical-period work in mice shows a period of increased
learning plasticity after acute drug effects and implicates
extracellular-matrix remodeling in that open state.
This supports a plasticity + directed rehabilitation hypothesis
rather than a simple analgesic model.
If adaptability temporarily rises, what follows may matter:
body scanning,
emotional processing,
safe sensory exposure,
previously feared movement,
progressive loading,
sleep,
supportive relationships,
environmental restructuring.
This is a research hypothesis, not an established fibromyalgia protocol.
Lion's mane + niacin + psilocybin: the Stamets convergence
The proposed combination is psilocybin + lion's mane + niacin (B3).
Observed pieces
Psilocybin: central/network plasticity signal.
Lion's mane: neurotrophic/NGF-related and peripheral
nerve-regeneration biology is strongest preclinically, with limited
human cognition/BDNF signals.
Niacin: peripheral vasodilation is well established; separate
experimental peripheral nerve/myelin biology is interesting.
A large prospective observational microdosing cohort found
mood/mental-health improvements among microdosers overall and
age-dependent psychomotor improvement in older adults. Combining
psilocybin with lion's mane and niacin did not clearly improve mood
outcomes; psychomotor subgroup findings remain hypothesis-generating.
Convergent inference
central plasticity + peripheral neurotrophic support + increased
perfusion
could create a more favorable environment for neural adaptation,
especially in a person with overlapping nociplastic and small-fiber
features.
The synergy itself is unproven.
Microdosing
A commonly discussed Stamets-style cadence is 5 days on / 2 days
off. It should be labeled FRONTIER N-of-1 practice, not an
established fibromyalgia regimen.
Controlled microdosing studies have generally been less impressive than
observational/community reports. The direct fibromyalgia signal
currently comes from structured supported higher-dose sessions, not
microdosing. These should be treated as different hypotheses.
For public discussion, the useful questions are:
Which phenotype would plausibly respond?
Does sensory sensitivity change?
Does movement confidence change?
Does sleep improve or worsen?
Are cognitive/psychomotor changes measurable?
Does any effect survive off-days?
Does adding lion's mane/niacin change the signal?
Plasticity windows and sequencing
A useful model is three scales of adaptive windows.
Micro window: minutes to hours
Potentially influenced by:
slow breathing,
body scanning,
heat,
MFR,
TENS,
exercise.
Use it for movement retraining, sensory reinterpretation, and safe
exposure.
Meso window: hours to days
Potentially influenced by:
exercise,
deep emotional processing,
metabolic perturbation/fasting,
intensive somatic work.
Use it for recovery, sleep, and repeated reinforcement.
Macro plasticity window: days or longer
Psychedelic critical-period work supports this concept preclinically.
Human duration and relevance to fibromyalgia are unknown.
A cautious conceptual sequence for clinician-supported psychedelic work
is:
prepare → supported experience → recover/observe → integrate
emotionally → introduce safe movement → progressively reclaim loading
and activities
Do not assume stacking extreme fasting, hard exercise, aggressive MFR,
heat, and a psychedelic session simultaneously is better. More stressors
are not automatically more therapeutic.
Daily life & personal exploration
The Life the Body Is Adapting To: Constraints, Environment, and Embedded Interventions
A treatment protocol is only one part of the input stream. The body is
adapting to the entire day: work posture, movement frequency, sleep
opportunity, caregiving, relationship dynamics, financial pressure, food
access, light exposure, social safety, commute, repetitive labor, and
perceived control.
This means "adherence" can be the wrong frame. A person may be highly
motivated while their environment continuously supplies stronger
opposing signals than the protocol supplies corrective ones.
Five common constraint families
Constraint
Examples
Loops potentially reinforced
Time / obligation
10-hour workday, childcare, eldercare, multiple jobs
money, healthcare access, food options, housing, transportation, exercise space
limits diagnosis, nutrition, recovery, equipment and treatment
Control / agency constraint
inability to choose breaks, workload, hours, sleep schedule, environment
chronic stress plus inability to remove a maintaining input
A sixth category, sleep opportunity/environment, should be separated
when shift work, infants, nighttime caregiving, noise, or irregular
schedules dominate the phenotype.
Example: 10 hours of static computer work can become 10 hours containing
frequent 30--90 second contraction/mobility interruptions, walking
calls, posture variation, outdoor-light breaks, and a short post-work
reset. The job remains; the biological signal changes.
Embedded intervention design
Put interventions inside existing obligations whenever possible: morning
outdoor light with coffee; body scan in the shower; calf
pumps/sit-to-stands/brief walking during desk work; walking phone calls;
floor mobility while playing with children; slow breathing during a
commute when safe; evening light reduction through the environment;
supplements attached to an existing meal.
Minimum viable / normal / high-capacity days
Minimum viable day --- ~5 minutes: preserve the signal during
chaos.
Normal day --- ~10--20 minutes: body scan +
regulation/expression + light release/movement.
High-capacity day --- 30--60+ minutes: longer release→move→load,
emotional work, heat, conditioning, or another targeted experiment.
Chronic emotional load
"Reduce stress" is often useless when the stressor is real and difficult
to escape. Distinguish removing the stressor, reducing exposure,
interrupting physiological carryover, changing the relationship to
unavoidable stress, and building enough capacity/agency to eventually
change the environment.
Repetitive movement, social safety, and information environment
For unavoidable repetitive work, modify frequency, force, range, speed,
workstation geometry, recovery interval, opposite movement, and tissue
capacity. Movement diversity itself is an input.
Social safety, belonging, touch, play, and meaningful connection affect
stress, sleep, autonomic state, and behavior. Constant symptom checking
and fear-based health content can also become threat-learning inputs.
The website should increase understanding, experimentation, and
agency, not fear.
Figure 5
Fit the change to the life you have
RemoveCan the unwanted demand be removed?
ReduceIf it remains, can there be less of it?
InterruptCan a long exposure be broken up?
CounterbalanceWhat can be built around the demand?
AdaptWhat remains workable on a difficult day?
The report’s desk-work example: the job stays; walking calls, posture changes, and brief movement breaks change the pattern of the day.
Section 31’s constraint framework. Read from top to bottom and stop at the changes that are feasible; this is a planning aid, not another routine to complete.
Hydration, Electrolytes, Minerals, and Water Quality
Hydration is not simply water volume. A better systems definition is:
adequate fluid + appropriate electrolytes/minerals + water quality
appropriate to the person's source and physiology.
Water and electrolytes affect blood/plasma volume, circulation,
orthostatic tolerance, thermoregulation, nerve conduction, muscle
contraction, exercise capacity, kidney function, and recovery.
Plain water versus electrolytes
For many healthy sedentary people eating a normal diet, ordinary water
plus food can supply adequate hydration and electrolytes.
Electrolyte replacement becomes more relevant with high sweat loss,
heat/sauna, prolonged exercise, diarrhea/vomiting, some
fasting/low-carbohydrate contexts, restricted diets, and
orthostatic/POTS-like physiology. Sodium and potassium are central to
fluid volume and nerve/muscle function; more is not automatically
better.
Mineral water
Natural mineral water can meaningfully contribute magnesium and calcium
depending on composition. Controlled human studies demonstrate
substantial magnesium bioavailability from magnesium-rich mineral water,
and distributed intake through the day can improve magnesium
absorption/retention.
The useful hierarchy is not automatically spring > filtered > tap.
It is:
known clean water with an appropriate mineral profile > unknown water
source.
Natural groundwater can itself contain arsenic, metals, radionuclides,
or microorganisms.
Municipal water and contaminants
Regulated municipal water is not inherently unsafe, but source and
plumbing matter. Possible exposures include lead/copper from plumbing,
naturally occurring arsenic/metals/radionuclides, PFAS, and disinfection
byproducts such as trihalomethanes and haloacetic acids.
Chlorination also prevents microbial disease. The stronger
chronic-exposure question is whether source-specific treatment
byproducts or plumbing contaminants justify filtration.
Practical water-quality workflow
Know the source: review the utility water-quality report or test
when old plumbing/private wells/source concerns justify it.
Identify the actual contaminant.
Choose filtration for that contaminant.
Check the relevant certification/contaminant-reduction claim, not
just "NSF certified."
If using reverse osmosis, remember that dissolved minerals are also
reduced; manage mineral intake intentionally.
For bottled spring/mineral water, inspect Mg, Ca, Na, bicarbonate,
and contaminant testing rather than branding.
The claim "coffee dehydrates fascia" is not well supported. The more
interesting caffeine question is collagen/ECM remodeling.
Fibroblast evidence
In cultured human fibroblasts, caffeine produced dose-dependent
suppression of collagen synthesis and altered prolidase, integrin, and
IGF-related signaling. In-vitro concentrations cannot be directly
translated into ordinary coffee consumption.
Evidence label: OBSERVED in vitro; human fascial consequence
INFERRED.
Tendon/ligament adaptation
A 2025 experimental study reported that caffeine reduced protein
synthesis in tendon cells and reduced collagen and mechanical strength
in engineered ligament constructs. In exercising mice, chronic caffeine
attenuated aspects of Achilles-tendon collagen adaptation.
Evidence label: SUPPORTED preclinically; direct human fascia harm not
demonstrated.
Adenosine, healing, and sleep
Caffeine antagonizes adenosine receptors. Adenosine signaling
participates in angiogenesis, ECM production, and wound repair.
Experimental literature suggests dose-dependent effects.
For fibromyalgia, the stronger real-world pathway may often be:
plus a possible direct connective-tissue adaptation effect.
Practical classification
Not an absolute do-not.
Strongly consider reducing high habitual caffeine with poor sleep, high
sympathetic/anxious state, tendon/connective-tissue problems,
myofascial-dominant symptoms, hypermobility/connective-tissue fragility,
poor exercise recovery, or heavy energy-drink use.
Low/moderate morning caffeine may be compatible with the protocol for
many people. Afternoon/evening caffeine deserves stronger reduction
because the sleep/circadian evidence is clearer than the direct fascia
evidence.
N-of-1 caffeine experiment
Establish 1--2 weeks baseline.
Track sleep, morning stiffness, pain, resting tension, exercise
recovery, ROM, and energy stability.
Reduce caffeine substantially for 4--6 weeks, especially later-day
caffeine.
5--10 min light feet/calves/hips release followed by active
movement.
Frequent walking/calf pumps during the day.
Consistent wake time + outdoor morning light.
Dimmer evening environment; blue blockers late evening if useful.
Adequate protein/energy/hydration.
Current supplement experiment, not ten new variables.
Daytime-aligned meals and a reasonable overnight food-free interval
if appropriate.
Medium adaptation day: about 1--2× weekly
heat → longer fascia work → active mobility → resistance → easy
aerobic work → food → sleep
Scale from the following 24--72-hour response.
Neuroplastic/emotional day
longer body scan,
EAET/PRT-style emotional processing,
gentle movement,
nature/social connection,
optional easy aerobic work.
Flexible capacity day
If recovered:
brisk walking,
cycling,
swimming,
coordination work,
light jump rope/rebounding if phenotype permits.
If not recovered: recovery is the intervention.
Figure 8
Relief and adaptation answer different questions
Immediately after a changeDid sensation, comfort, or range change? This is a clue about the response.
During the following recoveryDid sleep, fatigue, or delayed symptoms change? The after-effects belong in the observation.
Across repeated observationsIs daily function, capacity, or recovery improving? Look beyond a single good session.
What if I feel better briefly but worse later?
Record both. The report gives the later response a role in deciding whether to modify or abandon an experiment, rather than counting immediate relief alone as success.
Read how to define a useful outcome →An observation timeline, not a promised recovery schedule. The report gives no universal timetable for improvement.
N-of-1 debugging
Every experiment should answer a question.
Hypothesis: Which loop am I trying to change?
Intervention: What single major variable am I adding?
Keep stable: What other major inputs will remain similar?
Measures: pain, fatigue, sleep, morning stiffness, functional
capacity, flare duration, orthostatic symptoms, GI symptoms, sensory
sensitivity, mood/cognition as relevant.
Success criterion: define before starting.
Decision: continue, modify, or abandon.
Immediate relief is a clue, not proof. A useful intervention should
eventually improve capacity, recovery, symptom burden, or function.
Questions that move the idea forward
Figure 4
Turn a possibility into an answerable question
Name the questionWhich loop or symptom are you trying to understand?
Choose one main changeKeep other major inputs as similar as practical.
Define what countsChoose the outcome, a success criterion, and when to stop or seek advice.
Observe the responseTrack function and recovery as well as immediate symptoms.
Make a decisionContinue, modify, or abandon; use what you learned to refine the question.
Collect topics and questions in the exploration map →A visual summary of the report’s N-of-1 framework in section 25. Changes involving medicines, supplements, or specialist treatment need individual review with a qualified clinician.
What would take this model to the next level?
Better phenotyping
The field needs studies that stop treating all fibromyalgia patients as
biologically interchangeable.
Candidate stratifiers:
skin biopsy/corneal confocal microscopy for small fibers,
autonomic testing,
hypermobility/stability phenotype,
quantitative sensory testing,
sleep-disorder status,
insulin/metabolic indices,
immune/autoantibody signatures,
microbiome/metabolite patterns,
pressure-pain tolerance and other predictors of EAET/PRT response,
activity-response/PEM phenotype.
Combination and sequencing trials
Instead of asking whether isolated treatments beat placebo, test
sequences built around adaptation:
metabolic intervention → neuropathy and pain outcomes.
Measure subsystem outputs
Pain alone is not enough.
Track:
muscle phosphocreatine/strength,
HRV/orthostatic response,
sleep timing/architecture,
glucose/insulin indices,
small-fiber density/function,
ROM/stiffness,
exercise recovery,
GI/metabolite changes,
sensory amplification,
activity and participation.
Important failure modes
Mechanism laundering: a therapy works, therefore the proposed
mechanism must be correct. False.
RCT absolutism: the exact combination lacks an RCT, therefore it
is irrational. Also false.
Anecdote absolutism: someone recovered, therefore their
explanation is universal. False.
Kitchen-sink self-treatment: too many simultaneous variables
destroy learning.
Pain-chasing: intense sensation during treatment is not proof of
useful adaptation.
Ignoring phenotype: aggressive exercise in PEM or aggressive
stretching in hypermobility can be mismatched inputs.
Commercial evidence substitution: a plausible mechanism does not
validate a branded product.
Psychological reductionism: neural prediction and emotion can be
causal without making symptoms imaginary.
Peripheral reductionism: objective tissue/nerve abnormalities do
not prove central learning is irrelevant.
Confusing association with maintaining cause: abnormalities may
be causal, downstream, compensatory, or incidental.
Closing thesis
Fibromyalgia may be most productive to investigate not as one broken
component but as a stable, self-reinforcing physiological state that
different people reach through different routes.
The research challenge is to identify which loops are active in a given
person, choose leverage points that can be changed safely and
measurably, sequence those inputs intelligently, and observe whether the
system adapts.
That framing does not require certainty about the body's ultimate
capacity for recovery. It requires precision about what has been
observed, honesty about what is inferred, and enough openness to test
coherent ideas before the literature has finished catching up.
People & source maps
Researchers and practitioners worth following
Carla Stecco, MD --- fascial anatomy, HA, fasciacytes.
Ginevra Liptan, MD --- fascia/peripheral nociception in
fibromyalgia.
Anne Louise Oaklander, MD, PhD --- small-fiber neuropathy.
Andreas Goebel, MD/PhD and collaborators --- fibromyalgia
IgG/autoantibody work.
Amir Minerbi, MD, PhD / Arkady Khoutorsky, PhD --- microbiome
and fibromyalgia.
Daniel Clauw, MD --- nociplastic pain and fibromyalgia.
Kevin Boehnke, PhD / Jacob Aday, PhD --- psilocybin and chronic
pain.
Mark Lumley, PhD / Howard Schubiner, MD --- EAET and
learned/neural pain.
Alan Gordon, LCSW / Yoni Ashar, PhD / Tor Wager, PhD --- Pain
Reprocessing Therapy and predictive pain.